HOMA-IR: The Clinical Standard Index Reading Insulin Resistance in One Number

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is the clinical standard index quantifying insulin resistance from two measurements: fasting insulin and fasting glucose. The formula is (fasting insulin µU/mL × fasting glucose mg/dL) ÷ 405. Below 1.0 is normal. Above 1.5 signals concern. The October 2025 inositol meta-analysis of 898 patients in 18 RCTs reported -1.21 improvement, establishing HOMA-IR as a core metric for measurable metabolic health.

What it is

Insulin is a pancreatic hormone that regulates blood glucose and drives nutrient uptake into cells. In the normal state, one unit of insulin handles one unit of glucose. With insulin resistance, more insulin is needed to handle the same amount of glucose. The pancreas secretes more, but effect is reduced.

Direct measurement of this state is difficult. Precise testing requires university hospital clamp tests, which are time- and cost-intensive. The accessible alternative for general clinical practice is HOMA-IR. Two values measured during fasting (insulin and glucose) calculate one number expressing insulin resistance.

Calculation and measurement

Formula: HOMA-IR = (fasting insulin µU/mL × fasting glucose mg/dL) ÷ 405

Conditions: Blood draw after 8-12 hours of fasting. Typically morning first draw.

Tests required: Fasting insulin and fasting glucose. Both included in standard health checkups or available as add-on tests.

For example, fasting insulin 10 µU/mL and fasting glucose 90 mg/dL give HOMA-IR = (10 × 90) ÷ 405 = 2.22. Slightly above normal, suggesting some insulin resistance.

Reference and clinical cutoffs

Common HOMA-IR reference values.

Below 1.0: Normal insulin sensitivity. Insulin acts efficiently.

1.0-1.5: Borderline. Classified normal in some population averages, but follow-up recommended.

1.5-2.5: Mild insulin resistance. First-line domain for lifestyle intervention.

Above 2.5: Moderate or greater insulin resistance. Clinical evaluation and intervention warranted.

Above 3.0: Clear insulin resistance. Possibility of metabolic syndrome diagnosis.

These cutoffs vary by population and ethnicity. In Korean populations, some studies use 1.5 as the cutoff while others use 2.0. For self-tracking, change over time matters more than the absolute value of a single measurement.

Conditions that elevate HOMA-IR

Major conditions that raise HOMA-IR.

Overweight and central obesity: Visceral fat accelerates insulin resistance. Waist circumference shows strong correlation with insulin resistance.

PCOS (polycystic ovary syndrome): 50-70% of patients carry insulin resistance, one of the core mechanisms of PCOS.

Menopause: Estrogen decline reduces insulin sensitivity. HOMA-IR rises gradually in postmenopausal women.

Chronic stress: Cortisol elevation stimulates hepatic glucose production and reduces muscle insulin sensitivity.

Sleep deprivation: Sleep under 5 hours raises insulin resistance by close to 30% in short windows, per published data.

Processed food-heavy diet: Refined carbohydrates, liquid fructose, and trans fats accelerate insulin resistance.

Effective interventions

Multiple interventions for lowering HOMA-IR are clinically validated.

Resistance training: Directly increases muscle tissue insulin sensitivity. About 60 minutes weekly is the clinically meaningful threshold.

Aerobic exercise: Improves both insulin sensitivity and fat metabolism. 150 minutes weekly at moderate intensity is the standard.

Low-glycemic diet: Reduce refined carbs, increase fiber, raise protein proportion. Improvements of >0.5 HOMA-IR have been observed.

Inositol supplementation: The October 2025 systematic review pooling 18 RCTs and 898 participants reported -1.21 HOMA-IR. A clinically meaningful effect size.

Metformin: Among prescription medications, the most validated for insulin sensitivity. Requires physician prescription.

Time-restricted eating (TRE): 16:8 fasting and similar approaches show HOMA-IR improvements in some trials.

Vitamin D: Deficiency can accompany insulin resistance. Correcting deficiency is an effect domain.

Same-quarter announcement context

The October 2025 inositol systematic review in Diabetology & Metabolic Syndrome featured HOMA-IR as a primary metric. Pooling 18 RCTs and 898 participants over 4-24 weeks, inositol supplementation showed -1.21 HOMA-IR with moderate certainty in GRADE assessment.

Nestlé Research’s NAD+ booster study published the same quarter, showing increased SCFA production through microbiome adaptation, also connects to insulin sensitivity. SCFA stimulates GLP-1 secretion at the gut mucosa, and GLP-1 improves insulin sensitivity. NAD+ boosters, inositol, and GLP-1 medications all act in layered fashion on the same insulin sensitivity axis.

Self-measurement and tracking

General procedure for self-tracking HOMA-IR.

Initial test: Request fasting glucose and fasting insulin together at routine health checkup. Some packages include both, allowing automatic calculation. Direct calculation possible if both values are reported.

Calculation tools: Multiple free online HOMA-IR calculators. Just input insulin and glucose values for instant result.

Tracking frequency: 6-12 month intervals are common. Set baseline at the start of lifestyle intervention, then evaluate change at 12-24 weeks.

Interpretation: Time-trajectory matters more than absolute single value. A drop from 1.8 to 1.5 is a clinically meaningful improvement.

FAQ

Q. Is it okay if HOMA-IR is slightly elevated but glucose is normal?

This is a common pattern called “compensated hyperinsulinemia.” The pancreas is secreting more insulin to keep glucose normal. Long-term, as pancreatic capacity is exhausted, fasting glucose can rise as well, so isolated HOMA-IR elevation prompts lifestyle intervention.

Q. Is HOMA-IR measurement essential at PCOS diagnosis?

It is recommended. 50-70% of PCOS patients carry insulin resistance, and HOMA-IR informs decisions about inositol supplementation, metformin, and lifestyle interventions. With a PCOS diagnosis, follow up at 6-12 month intervals.

Q. Does HOMA-IR naturally rise after menopause?

Estrogen decline accelerates insulin sensitivity loss, so some natural rise occurs. However, not all postmenopausal women experience the same rate. Lifestyle variables (exercise, diet, sleep) and supplementation (inositol and others) shape the trajectory.

Q. Does excessive fasting time skew HOMA-IR?

8-12 hours is the standard. Measurement after 16+ hours of fasting yields abnormally low insulin readings, making HOMA-IR appear lower than actual. Measuring close to 12 hours of fasting is the standard recommendation.

Q. Can it be measured right after exercise?

Resistance training transiently increases insulin sensitivity for up to 24 hours, so measurements may run lower than usual. For consistent tracking, exercise on the same pattern and measure on the same day and time.